Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

Clinical trial NCT04758650 · TERMINATED

Trial details

NCT number: NCT04758650
Sponsor: Universitair Ziekenhuis Brussel
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Malignancy Located in the Head and Neck Cancer Carotid Stenosis Atherosclerosis of Artery Hodgkin Lymphoma, Adult Non Hodgkin Lymphoma HLH Cardiac Sarcoidosis Sarcoidosis

Start date: 2021-01-26
Primary completion: 2025-01-08
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.